Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of COVID‐19 patients with a SARS‐CoV‐2‐specific siRNA‐peptide dendrimer formulation
Musa Khaitov, Alexandra Nikonova, И.А. Кофиади, et al.
Allergy (2023) Vol. 78, Iss. 6, pp. 1639-1653
Open Access | Times Cited: 17

Showing 17 citing articles:

Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period
Danyi Ao, Xuemei He, Jian Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Antiviral Therapy of COVID-19
Georgii Gudima, И.А. Кофиади, I.P. Shilovskiy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8867-8867
Open Access | Times Cited: 24
Dendrimer-Mediated Delivery of DNA and RNA Vaccines
L. A. Kisakova, Evgeny Apartsin, L. F. Nizolenko, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 21
Importance, Applications and Features of Assays Measuring SARS-CoV-2 Neutralizing Antibodies
Pia Gattinger, Anna Ohradanova‐Repic, Rudolf Valenta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5352-5352
Open Access | Times Cited: 19
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV
Ellen Bowden-Reid, Ernest Moles, Anthony D. Kelleher, et al.
Drug Delivery and Translational Research (2025)
Open Access
Phase 2‐3 Trial: Prevention of the Progression to Moderate and Severe COVID‐19 in SARS‐CoV‐2‐Infected Non‐Hospitalized Adults With Inhaled siRNA‐Based MIR 19
Musa Khaitov, Alexandra Nikonova, В. П. Смирнов, et al.
Allergy (2025)
Closed Access
Cell-Penetrating Peptides as Vehicles for Delivery of Therapeutic Nucleic Acids. Mechanisms and Application in Medicine
E.D. Timotievich, I.P. Shilovskiy, Musa Khaitov
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1800-1817
Open Access | Times Cited: 11
Vaccine Based on Recombinant Fusion Protein Combining HBV PreS with SARS-CoV-2 Wild-Type- and Omicron-Derived RBD Strongly Induces Omicron-Neutralizing Antibodies
Pia Gattinger, Bernhard Kratzer, Al Nasar Ahmed Sehgal, et al.
(2024)
Open Access | Times Cited: 1
SiRNAs as antiviral drugs – Current status, therapeutic potential and challenges.
Trairong Chokwassanasakulkit, Victor B. Oti, Adi Idris, et al.
Antiviral Research (2024), pp. 106024-106024
Open Access | Times Cited: 1
Results of clinical trials phases I and II of MIR 19®
Musa Khaitov, Alexandra Nikonova, И.А. Кофиади, et al.
Immunologiya (2023) Vol. 44, Iss. 3, pp. 291-316
Open Access | Times Cited: 2
Integration of Dendrimer‐Based Delivery Technologies with Computational Pharmaceutics and Their Potential in the Era of Nanomedicine
Karnaker R. Tupally, Prasenjit Seal, Preeti Pandey, et al.
(2024), pp. 328-378
Closed Access
Application of therapeutic nucleic acids and RNA interference to create products for personalised medicine
I.P. Shilovskiy, G.B. Pasikhov, Smirnov Vv, et al.
Biological Products Prevention Diagnosis Treatment (2024) Vol. 24, Iss. 2, pp. 157-171
Open Access
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA
A Sakai, Gagandeep Singh, Mahsa Khoshbakht, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102331-102331
Open Access
Designing Cell Delivery Peptides and SARS-CoV-2-Targeting Small Interfering RNAs: A Comprehensive Bioinformatics Study with Generative Adversarial Network-Based Peptide Design and In Vitro Assays
Ricardo González, Susana Simões, Lino Ferreira, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6079-6089
Closed Access | Times Cited: 1
Synthetic siRNA molecules suppress Il4 and Il13 gene expression and reduce allergic inflammation and remodeling of upper airways in mouse model
I.P. Shilovskiy, E.D. Timotievich, M.M. Kaganova, et al.
Immunologiya (2023) Vol. 44, Iss. 5, pp. 586-606
Open Access
Suppression of respiratory syncytial virus infection in vitro by small interfering RNAs complexed with bifunctional peptide carrier
E.D. Timotievich, I.P. Shilovskiy, K.V. Yumashev, et al.
Immunologiya (2023) Vol. 44, Iss. 5, pp. 545-556
Open Access
Peptide carriers as delivery vehicles for therapeutic nucleic acids. Мechanisms and potential applications in medicine
E.D. Timotievich, I.P. Shilovskiy, Musa Khaitov
Биохимия (2023) Vol. 88, Iss. 11, pp. 2183-2205
Closed Access
Page 1

Scroll to top